About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.
About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.
Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
Previous research indicated six weeks of treatment improved hearing, but new findings published in the New England Journal of Medicine reveal six months is better.Babies treated for symptomatic cytomegalovirus (CMV) infection for six months, instead of the standard six weeks, have better hearing and developmental outcomes, according to a new study from the University of Alabama at Birmingham. One in 150 babies will be born with CMV, and about one of every five of those children will develop permanent hearing loss or have developmental disabilities, according to the Centers for Disease Control and Prevention. CMV is the most common infection passed from a mother to her unborn child, and there is no vaccine or cure for it. David Kimberlin, M.D., professor and co-director of the UAB Division of Pediatric Infectious Diseases at Children’s of Alabama and president of the Pediatric Infectious Diseases Society, and colleagues from about 30 other academic medical centers...
The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid. The University of Alabama at Birmingham has launched two studies of cannabidiol oil, or CBD oil, as a treatment for severe, intractable seizures. The two studies, an adult study at UAB and a pediatric study at Children’s of Alabama, were authorized by the Alabama Legislature in 2014 by legislation known as Carly’s Law. The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid. “We are extremely pleased to launch these exciting studies,” said David Standaert, M.D., Ph.D., chair of the Department of Neurology. “What we learn from these investigations could have a profound impact on...
William S. Tuten, O.D., Ph.D., will present on the use of adaptive optics ophthalmoscopes to increase understanding of photoreceptor cells.The University of Alabama at Birmingham School of Optometry will host William S. Tuten, O.D., Ph.D., clinical scientist, University of California, Berkeley Vision Science Program, as its visiting scholar. Tuten will present “Using adaptive optics to study structure and function at the cellular scale in retinal disease” at noon Monday, March 2, in the Worrell Conference Room in the Henry Peters Building, 1716 University Blvd. The seminar will discuss the use of adaptive optics ophthalmoscopes to capture images of the human retina during the past two decades. This gave scientists unprecedented access into individual photoreceptor cells and increased the understanding of their structure in normal eyes and in those with retinal disease.